Evidence map›Paper›PMID 36525051›Full record

ReviewAbdominal radiology (New York)2023

PET/MRI imaging in neuroendocrine neoplasm.

Mayur K Virarkar, Matthew Montanarella, Malak Itani, Luis Calimano-Ramirez, Dheeraj Gopireddy, Priya Bhosale

Abstract readReview
PubMed Publisher
In one paragraph

Review in Abdominal radiology (New York), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Intra-individual qualitative and quantitative comparison of [Therapeutic advances in medical oncology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Mayur K VirarkarDepartment of Radiology, University of Florida College of Medicine, Jacksonville, FL, 32209, USA.
Matthew MontanarellaDepartment of Radiology, University of Florida College of Medicine, Jacksonville, FL, 32209, USA.
Malak ItaniMallinckrodt Institute of Radiology, Washington University in St. Louis School of Medicine, 510 S Kings Highway Blvd, Campus Box 8131, St Louis, MO, 63110, USA.
Luis Calimano-RamirezDepartment of Radiology, University of Florida College of Medicine, Jacksonville, FL, 32209, USA. luis.calimanoramirez@jax.ufl.edu.ORCID 0000-0003-2599-3179
Dheeraj GopireddyDepartment of Radiology, University of Florida College of Medicine, Jacksonville, FL, 32209, USA.
Priya BhosaleDivision of Diagnostic Imaging, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
University of Florida · USThe University of Texas MD Anderson Cancer Center · USWashington University in St. Louis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Molecular imaging plays a vital role in the management of neuroendocrine neoplasms (NENs). Somatostatin receptor (SSTR) PET is critical for evaluating NENs, ascertaining peptide receptor radionuclide therapy (PRRT) eligibility, and treatment response. SSTR-PET/MRI can provide a one-stop-shop multiparametric evaluation of NENs. The acquisition of complementary imaging information in PET/MRI has distinct advantages over PET/CT and MR imaging acquisitions. The purpose of this manuscript is to provide a comprehensive overview of PET/MRI and a current review of recent PET/MRI advances in the diagnosis, staging, treatment, and surveillance of NENs.

Indexed as

Neuroendocrine TumorsPositron Emission Tomography Computed TomographyHumansMagnetic Resonance ImagingPositron-Emission TomographyReceptors, SomatostatinReceptors, SomatostatinNeuroendocrine neoplasmPET/CTPET/MRIPPRTSSTR

Identifiers

PMID36525051
OpenAlexW4311671238

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.